Cargando…

Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis

BACKGROUND: The thioflavin T derivative, (11)C-Pittsburgh-B (PIB), is used for Alzheimer's disease imaging because it specifically binds to β-amyloid protein deposits in the brain. The aim of this study was to estimate the diagnostic value of combined (11)C-PIB positron emission tomography/magn...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Xiao, Xu, Baixuan, Liu, Jiajin, Wang, Guanyun, An, Jing, Zhang, Xiaojun, Wang, Ruimin, Dong, Wei, Guan, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966842/
https://www.ncbi.nlm.nih.gov/pubmed/35369284
http://dx.doi.org/10.3389/fcvm.2022.830572
_version_ 1784678719103696896
author Bi, Xiao
Xu, Baixuan
Liu, Jiajin
Wang, Guanyun
An, Jing
Zhang, Xiaojun
Wang, Ruimin
Dong, Wei
Guan, Zhiwei
author_facet Bi, Xiao
Xu, Baixuan
Liu, Jiajin
Wang, Guanyun
An, Jing
Zhang, Xiaojun
Wang, Ruimin
Dong, Wei
Guan, Zhiwei
author_sort Bi, Xiao
collection PubMed
description BACKGROUND: The thioflavin T derivative, (11)C-Pittsburgh-B (PIB), is used for Alzheimer's disease imaging because it specifically binds to β-amyloid protein deposits in the brain. The aim of this study was to estimate the diagnostic value of combined (11)C-PIB positron emission tomography/magnetic resonance (PET/MR) in cardiac amyloidosis (CA). METHODS: We enrolled 23 heart failure patients with suspected CA based on echocardiographic and electrocardiograph findings. All patients underwent cardiac (11)C-PIB PET/MR and non-cardiac biopsy within one week. We also enrolled eight healthy volunteers that underwent cardiac (11)C-PIB PET/MR as a control group. The cardiac magnetic resonance (CMR) protocol included cine imaging, late gadolinium enhancement (LGE), and native and post-contrast T1 mapping. Extracellular volume (ECV) was measured using pre- and post-contrast T1 mapping images. LVEF, IVSD, LVPW, LVmass, LVESV, LVEDV, native T1 value, ECV, and maximum uptake of myocardial tissue-to-blood background ratio (TBR) values were obtained from PET/MR images in all patients and healthy subjects. RESULTS: Thirteen out of twenty-three heart failure patients were clinically diagnosed with CA. The remaining 10 patients were CA-negative (non-CA patient group). Twelve of the thirteen CA patients showed diffuse transmural LGE patterns, whereas LGE was either absent or patchy in the non-CA patients. The diagnostic sensitivity and specificity of TBRmax were 92.3 and 100%, respectively, at a cut-off value of 1.09. Several CMR imaging parameters (LVEF, IVSD, LVmass, LVEDV, LVESV, LVPW, native T1 value and ECV) and TBR showed significant differences between CA patients, non-CA patients, and healthy controls (P < 0.05). Native T1 mapping values positively correlated with TBRmax values in CA and non-CA patients (r = 0.38, P = 0.0004). CONCLUSIONS: (11)C-PIB PET/MRI is a valuable tool for the accurate and non-invasive diagnosis of CA because it distinguishes CA patients from non-CA patients and healthy subjects with high specificity and sensitivity. Moreover, native T1 mapping values positively correlated with TBRmax values in CA and non-CA patients. In the future, larger cohort studies are necessary to confirm our findings.
format Online
Article
Text
id pubmed-8966842
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89668422022-03-31 Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis Bi, Xiao Xu, Baixuan Liu, Jiajin Wang, Guanyun An, Jing Zhang, Xiaojun Wang, Ruimin Dong, Wei Guan, Zhiwei Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: The thioflavin T derivative, (11)C-Pittsburgh-B (PIB), is used for Alzheimer's disease imaging because it specifically binds to β-amyloid protein deposits in the brain. The aim of this study was to estimate the diagnostic value of combined (11)C-PIB positron emission tomography/magnetic resonance (PET/MR) in cardiac amyloidosis (CA). METHODS: We enrolled 23 heart failure patients with suspected CA based on echocardiographic and electrocardiograph findings. All patients underwent cardiac (11)C-PIB PET/MR and non-cardiac biopsy within one week. We also enrolled eight healthy volunteers that underwent cardiac (11)C-PIB PET/MR as a control group. The cardiac magnetic resonance (CMR) protocol included cine imaging, late gadolinium enhancement (LGE), and native and post-contrast T1 mapping. Extracellular volume (ECV) was measured using pre- and post-contrast T1 mapping images. LVEF, IVSD, LVPW, LVmass, LVESV, LVEDV, native T1 value, ECV, and maximum uptake of myocardial tissue-to-blood background ratio (TBR) values were obtained from PET/MR images in all patients and healthy subjects. RESULTS: Thirteen out of twenty-three heart failure patients were clinically diagnosed with CA. The remaining 10 patients were CA-negative (non-CA patient group). Twelve of the thirteen CA patients showed diffuse transmural LGE patterns, whereas LGE was either absent or patchy in the non-CA patients. The diagnostic sensitivity and specificity of TBRmax were 92.3 and 100%, respectively, at a cut-off value of 1.09. Several CMR imaging parameters (LVEF, IVSD, LVmass, LVEDV, LVESV, LVPW, native T1 value and ECV) and TBR showed significant differences between CA patients, non-CA patients, and healthy controls (P < 0.05). Native T1 mapping values positively correlated with TBRmax values in CA and non-CA patients (r = 0.38, P = 0.0004). CONCLUSIONS: (11)C-PIB PET/MRI is a valuable tool for the accurate and non-invasive diagnosis of CA because it distinguishes CA patients from non-CA patients and healthy subjects with high specificity and sensitivity. Moreover, native T1 mapping values positively correlated with TBRmax values in CA and non-CA patients. In the future, larger cohort studies are necessary to confirm our findings. Frontiers Media S.A. 2022-03-16 /pmc/articles/PMC8966842/ /pubmed/35369284 http://dx.doi.org/10.3389/fcvm.2022.830572 Text en Copyright © 2022 Bi, Xu, Liu, Wang, An, Zhang, Wang, Dong and Guan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Bi, Xiao
Xu, Baixuan
Liu, Jiajin
Wang, Guanyun
An, Jing
Zhang, Xiaojun
Wang, Ruimin
Dong, Wei
Guan, Zhiwei
Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis
title Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis
title_full Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis
title_fullStr Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis
title_full_unstemmed Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis
title_short Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis
title_sort diagnostic value of (11)c-pib pet/mr in cardiac amyloidosis
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966842/
https://www.ncbi.nlm.nih.gov/pubmed/35369284
http://dx.doi.org/10.3389/fcvm.2022.830572
work_keys_str_mv AT bixiao diagnosticvalueof11cpibpetmrincardiacamyloidosis
AT xubaixuan diagnosticvalueof11cpibpetmrincardiacamyloidosis
AT liujiajin diagnosticvalueof11cpibpetmrincardiacamyloidosis
AT wangguanyun diagnosticvalueof11cpibpetmrincardiacamyloidosis
AT anjing diagnosticvalueof11cpibpetmrincardiacamyloidosis
AT zhangxiaojun diagnosticvalueof11cpibpetmrincardiacamyloidosis
AT wangruimin diagnosticvalueof11cpibpetmrincardiacamyloidosis
AT dongwei diagnosticvalueof11cpibpetmrincardiacamyloidosis
AT guanzhiwei diagnosticvalueof11cpibpetmrincardiacamyloidosis